Global Latex Agglutination Test Kits Market Report 2024

The latex agglutination test kits market size has grown strongly in recent years. It will grow from $1.39 billion in 2023 to $1.49 billion in 2024 at a compound annual growth rate (CAGR) of 7%. The growth observed during the historic period can be attributed to several factors, including the increase in the prevalence of infectious diseases, heightened funding for research and development in diagnostics, a greater focus on infection control measures in healthcare facilities, and the increased adoption of latex agglutination tests in water quality testing.

The latex agglutination test kits market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The anticipated growth in the forecast period can be attributed to several factors, including the rising prevalence of infectious and autoimmune diseases, the increasing adoption of rapid and point-of-care (POC) technology, the growing awareness about sexually transmitted infections, and the rising incidence of respiratory tract infections. Major trends expected in the forecast period include technological advancements, the utilization of test strip technology, the development of antigen tests, the adoption of automated technologies, and the expansion of point-of-care testing.

The surge in infectious diseases prevalence is anticipated to propel the expansion of the latex agglutination test kit market in the foreseeable future. Infectious diseases, stemming from pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions, are on the rise due to globalization, antimicrobial resistance, urbanization, climate change, and population growth. Latex agglutination tests serve as a rapid detection method for various infectious diseases, including bacterial and viral infections. For example, data from UNAIDS indicates a global HIV population of 39 million in 2022, marking a 3.17% increase from 2020, with approximately 1.3 million new HIV infections reported. Additionally, the Centers for Disease Control and Prevention reported 8,331 tuberculosis cases in the United States in 2022, representing a 5.9% rise from the previous year. Hence, the escalating prevalence of infectious diseases is poised to fuel the latex agglutination test kit market's growth.

Leading companies in the latex agglutination test kits market are concentrating on introducing diagnostic technologies for foodborne illnesses and environmental contaminants. They aim to enhance disease diagnosis and gain a competitive advantage by offering rapid and user-friendly latex agglutination assays. These assays streamline pathogen detection, providing quick and straightforward identification in food and environmental samples. For instance, Gold Standard Diagnostics LLC launched Microgen rapid latex agglutination tests in March 2024. These tests, designed for confirming the diagnosis of specific pathogens such as Salmonella, Legionella, or Staphylococcus aureus colonies in food and environmental samples, offer rapid, easy, and cost-effective techniques. They serve as highly sensitive and specific alternatives to conventional culture procedures, completing within as little as two minutes and seamlessly integrating into laboratory workflows. Their simplicity allows labs to utilize them immediately without requiring specialized training or equipment.

In January 2023, Gold Standard Diagnostics LLC acquired Microgen Bioproducts Ltd., a UK-based biotechnology company specializing in diagnostic test kits and instruments, including latex agglutination tests for identifying bacteria. This acquisition aims to broaden Gold Standard Diagnostics LLC's portfolio of diagnostic test kits and instruments.

Major companies operating in the latex agglutination test kits market are Cardinal Health Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Hardy Diagnostics, Meridian Bioscience Inc., BioLegend Inc., ELITechGroup, Fujirebio, Sekisui Diagnostics LLC, R-Biopharm AG, Savyon Diagnostics Ltd., Creative Diagnostics, ZeptoMetrix Corporation, HiMedia Laboratories, DIALAB GmbH, Arlington Scientific Inc., Biotium Inc., Atlas Medical GmbH, Pro Lab Diagnostics Inc., Gold Standard Diagnostics Industrial Solutions.

North America was the largest region in the latex agglutination test kits market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the latex agglutination test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the latex agglutination test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Latex agglutination test kits serve as vital diagnostic tools in clinical settings, facilitating the identification of specific antigens or antibodies in biological materials. Operating on the principle of antigen-antibody interactions, these kits offer rapid and precise detection of various infectious diseases, thereby aiding in timely treatment and containment efforts. Due to their versatility and reliability, they are extensively utilized in laboratories.

The main product types of latex agglutination test kits include enzyme-linked immunosorbent assay, indirect fluorescent, hemagglutination inhibition, and serum neutralization. Enzyme-linked immunosorbent assay (ELISA) is a type of test wherein enzymes aid in detecting antibodies or antigens in a sample. Widely employed in laboratories for diagnosing diseases or monitoring health conditions such as infectious diseases or allergies, ELISA encompasses antibody detection and antigen testing. These tests are conducted on sample types such as blood, urine, cerebrospinal fluid, and others, and are applied across various settings including hospitals, diagnostic centers, and specialty clinics.

The latex agglutination test kits market research report is one of a series of new reports that provides latex agglutination test kits market statistics, including latex agglutination test kits industry global market size, regional shares, competitors with a latex agglutination test kits market share, detailed latex agglutination test kits market segments, market trends and opportunities, and any further data you may need to thrive in the latex agglutination test kits industry. This latex agglutination test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The latex agglutination test kits market consists of sales of microbial identification kits, serological test kits, and blood typing kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.